Fortress Biotech, Inc. (FBIO) vs Nordicus Partners Corporation (NORD)
- Fortress Biotech, Inc. FBIO 1.85 +0.54%
- Nordicus Partners Corporation NORD 3.22 −0.92%
Fortress Biotech, Inc. and Nordicus Partners Corporation are both Biotechnology companies. Fortress Biotech, Inc. and Nordicus Partners Corporation are of similar size ($63.2M and $61.4M). Nordicus Partners Corporation has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against −71.7%. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs −4.43%). Across the 18 metrics below, Fortress Biotech, Inc. leads on 13 and Nordicus Partners Corporation on 5.
Valuation
Profitability
| Metric | FBIO | NORD | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | 70.18% | 68.51% |
| Operating margin | (42.61%) | 0.00% | 0.00% |
| Net margin | 150.98% | 0.00% | 0.00% |
| Free cash flow margin | 183.80% | 0.00% | 0.00% |
| Return on equity | 84.91% | (8.06%) | (51.96%) |
| Return on assets | 43.38% | (6.80%) | (46.06%) |
| Return on invested capital | (41.34%) | (4.43%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack